Company remains on track to submit Investigational Device Exemption (“IDE”), and if approved, commence U.S. clinical trials in 2026 to support a De Novo FDA application THE WOODLANDS, TX, Sept. 29, ...

The "GLP Laboratory Compliance Documentation and Recordkeeping" training has been added to ResearchAndMarkets.com's offering.

Dear reader, the pharmaceutical industry plays a crucial role in protecting human health, which necessitates stringent ...

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced that its unified platform for research and clinical informatics has been validated to comply ...